Hip Joint Reclassification Petition May Be Reviewed By Panel In November
This article was originally published in The Gray Sheet
Executive Summary
FDA's Orthopedic Devices Panel is expected to review at its next meeting a petition from the Orthopedic Surgical Manufacturers Association requesting that the agency reclassify constrained metal/polymer hip joint prostheses, according to the association.
You may also be interested in...
FDA Advisory Panel To Evaluate Computer-Assisted Orthopedic Devices
The use of radiologic and other intraoperative assessments as surrogate endpoints for computer-assisted surgical technologies in orthopedic use will be discussed by FDA's Orthopedics and Rehabilitation Devices advisory committee at its November 4 meeting, according to an agency memo issued to panel members.
FDA Advisory Panel To Evaluate Computer-Assisted Orthopedic Devices
The use of radiologic and other intraoperative assessments as surrogate endpoints for computer-assisted surgical technologies in orthopedic use will be discussed by FDA's Orthopedics and Rehabilitation Devices advisory committee at its November 4 meeting, according to an agency memo issued to panel members.
OSTEONICS APPROVAL FOR CONSTRAINED ACETABULAR INSERT CLEARS WAY FOR CONTINUED MARKETING; J&J S-ROM POLY-DIAL ACETABULAR LINE RECOMMENDED FOR APPROVAL
Osteonics' constrained acetabular insert received FDA approval June 13, allowing the firm to continue marketing the preamendments Class III device. The approval came only three days after FDA's Orthopedic and Rehabilitation Devices Panel unanimously recommended on June 10 that the device was approvable with conditions.
Need a specific report? 1000+ reports available
Buy Reports
Register for our free email digests: